FNCH
Finch Therapeutics Group, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Mark Smith
IPO Date
2021-03-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Finch Therapeutics Group, Inc.
CEO
Mark Smith
IPO Date
2021-03-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 384 |
| $0.00 |
| 24 May 2024 | SMISEK JEFFERY A | director | G-Gift | Disposed | 3,750 | $0.00 |
| 29 Mar 2024 | SMISEK JEFFERY A | director | S-Sale | Disposed | 1,600 | $2.61 |
| 29 Mar 2024 | SMISEK JEFFERY A | director | S-Sale | Disposed | 6,642 | $2.57 |
| 27 Nov 2023 | SMISEK JEFFERY A | director | S-Sale | Disposed | 1,470 | $3.64 |
| 9 Jun 2023 | Graf Susan E | director | A-Award | Acquired | 10,000 | $0.28 |
| 9 Jun 2023 | Graf Susan E | director | P-Purchase | Acquired | 5,010 | $0.27 |
| 9 Jun 2023 | FERRANTE DOMENIC J | director | A-Award | Acquired | 10,000 | $0.28 |
| 9 Jun 2023 | SMISEK JEFFERY A | director | A-Award | Acquired | 10,000 | $0.28 |